Chemical Name: (4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-(2-((S)-2-((S)-2-((S)-2-(2-((S)-2-((S)-2-((R)-2-((S)-2-(2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-1-(L-prolylglycyl-L-glutaminyl-L-glutamyl-L-histidyl)pyrrolidine-2-carboxamido)-4-amino-4-oxobutanamido)propanamido)-5-guanidinopentanamido)-6-aminohexanamido)-3-(4-hydroxyphenyl)propanamido)-6-aminohexanamido)acetamido)propanamido)-4-amino-4-oxobutanamido)-6-aminohexanamido)-6-aminohexanamido)acetamido)-4-methylpentanamido)-3-hydroxypropanamido)-6-aminohexanamido)acetamido)-40-(4-aminobutyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-31-(3-guanidinopropyl)-16,22-bis(hydroxymethyl)-10,37,43-triisobutyl-19-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carboxylic acid
Shipping Temperature: Ambient
Country of Origin: India
Smiles: CC[C@@H]([C@H]1C(NCC(N[C@@H](CO)C(N[C@@H](CCSC)C(N[C@@H](CO)C(NCC(N[C@@H](CC(C)C)C(NCC(N[C@H](C(O)=O)CSSC[C@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]2CCCN2C([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H]3CCCN3)=O)=O)CCC(N)=O)=O)CCC(O)=O)=O)CC4=CN=CN4)=O)=O)CC(N)=O)=O)C)=O)CCCNC(N)=N)=O)CCCCN)=O)CC5=CC=C(O)C=C5)=O)CCCCN)=O)=O)C)=O)CC(N)=O)=O)CCCCN)=O)CCCCN)=O)=O)CC(C)C)=O)CO)=O)CCCCN)=O)=O)C(N[C@@H](CC6=CC=CC=C6)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N1)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C
Vosoritide Des Asn-15 Impurity is chemically (4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-(2-((S)-2-((S)-2-((S)-2-(2-((S)-2-((S)-2-((R)-2-((S)-2-(2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-1-(L-prolylglycyl-L-glutaminyl-L-glutamyl-L-histidyl)pyrrolidine-2-carboxamido)-4-amino-4-oxobutanamido)propanamido)-5-guanidinopentanamido)-6-aminohexanamido)-3-(4-hydroxyphenyl)propanamido)-6-aminohexanamido)acetamido)propanamido)-4-amino-4-oxobutanamido)-6-aminohexanamido)-6-aminohexanamido)acetamido)-4-methylpentanamido)-3-hydroxypropanamido)-6-aminohexanamido)acetamido)-40-(4-aminobutyl)-49-benzyl-28-((S)-sec-butyl)-34-(carboxymethyl)-31-(3-guanidinopropyl)-16,22-bis(hydroxymethyl)-10,37,43-triisobutyl-19-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane-4-carboxylic acid. Vosoritide Des Asn-15 Impurity is supplied with detailed characterization data compliant with regulatory guideline. Vosoritide Des Asn-15 Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vosoritide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. Vsquare products are for analytical purpose only and not for human use.

